Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion Plan

AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer

Ruchika Sharma12 Sept 2023 1:30 PM IST

Cambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer, BioNTech gets USFDA nod for 2023-2024 COVID vaccine

Ruchika Sharma12 Sept 2023 12:30 PM IST

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...

GSK regulatory submission for myelofibrosis medicine momelotinib accepted for review by Japanese regulator

Ruchika Sharma12 Sept 2023 11:29 AM IST

London: GSK plc has announced that the Ministry of Health, Labour and Welfare (MHLW), Japan, has accepted for review a new drug application (NDA) for...

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline

SC relief to GSK, junks plea claiming deficiency of service by Pharma company on account of alleged vaccine side effects

Ruchika Sharma11 Sept 2023 3:14 PM IST

The apex court said that non-mentioning of myositis as an adverse reaction in the literature accompanying the injection or on the vial, did not amount...

Indian pharma industry to log in 8-10 percent revenue growth this fiscal: Crisil

Ruchika Sharma11 Sept 2023 2:58 PM IST

New Delhi: The Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 per cent in current fiscal aided by a steady domestic...

Sandoz gets exclusive rights to commercialize biosimilar SB17 ustekinumab in US, Canada, EEA, Switzerland and UK

Ruchika Sharma11 Sept 2023 1:30 PM IST

The reference medicine Stelara (ustekinumab) is a monoclonal antibody medication to interleukin (IL)-12/23 for the treatment of autoimmune disorders...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche open to big acquisitions 'if it makes scientific and financial sense', CEO tells NZZ am Sonntag

Ruchika Sharma11 Sept 2023 12:23 PM IST

Zurich: Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker...

Strides Pharma Science Acetaminophen and Ibuprofen Tablets

Strides Pharma Science Singapore arm gets USFDA nod for Sevelamer Carbonate for Oral Suspension

Ruchika Sharma11 Sept 2023 11:39 AM IST

Sevelamer Carbonate for Oral Suspension is a medication used to manage elevated levels of phosphate in the blood of patients with chronic kidney...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna, Immatics collaborate to develop innovative oncology therapeutics

Ruchika Sharma11 Sept 2023 10:00 AM IST

Cambridge: Moderna, Inc. and Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting...

Daiichi Sankyo DS-3939 enters clinical development in patients across several types of advanced solid cancers

Ruchika Sharma10 Sept 2023 3:54 PM IST

Tokyo: Daiichi Sankyo has announced that the first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS-3939 in patients with...

Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine

Ruchika Sharma10 Sept 2023 2:30 PM IST

New York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...

Merck, Portage Biotech collaborate to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda in solid tumors

Ruchika Sharma10 Sept 2023 11:30 AM IST

Westport: Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok